2021
DOI: 10.2807/1560-7917.es.2021.26.9.2100133
|View full text |Cite|
|
Sign up to set email alerts
|

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

Abstract: The emergence of SARS-CoV-2 variant 20I/501Y.V1 (VOC-202012/1 or GR/501Y.V1) is concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% of all positive tests) performed on 7–8 January 2021 in France. The prevalence of 20I/501Y.V1 was 3.3% among positive tests nationwide and 6.9% in the Paris region. Analysing the recent rise in the prevalence of 20I/501Y.V1, we estimate that, in the French context, 20I/501Y.V1 is 52–69% more transmissible than the previously circulating li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

7
67
1
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 79 publications
(81 citation statements)
references
References 3 publications
7
67
1
1
Order By: Relevance
“…Since January 2021, the national guideline is to test all clinical samples that are positive for SARS-CoV-2 with an additional reverse-transcription (RT)-PCR to detect mutations indicative of certain variants [7,8] We used the ID SARS-CoV-2/N501Y/E484K Quadruplex assay (ID Solution, Grabels, France) to test 53,687 SARS-CoV-2 positive samples collected between 12 April and 7 May 2021 in 13 French regions, with the majority of samples coming from the Île-de-France region (Table 1). Some of the total samples (7-8%, Table 1) originated from hospitals (mostly hospitalised patients), the rest from the general population.…”
Section: Pcr Testing Of Sars-cov-2-positive Clinical Samples For Variantsmentioning
confidence: 99%
“…Since January 2021, the national guideline is to test all clinical samples that are positive for SARS-CoV-2 with an additional reverse-transcription (RT)-PCR to detect mutations indicative of certain variants [7,8] We used the ID SARS-CoV-2/N501Y/E484K Quadruplex assay (ID Solution, Grabels, France) to test 53,687 SARS-CoV-2 positive samples collected between 12 April and 7 May 2021 in 13 French regions, with the majority of samples coming from the Île-de-France region (Table 1). Some of the total samples (7-8%, Table 1) originated from hospitals (mostly hospitalised patients), the rest from the general population.…”
Section: Pcr Testing Of Sars-cov-2-positive Clinical Samples For Variantsmentioning
confidence: 99%
“…Even if epidemic growth is initially slow, it may accelerate over time and become less manageable for example because of a saturation of resources for testing and contact tracing, increased risk of superspreading events, changing climate conditions [ 11 ] or spatial expansion. An increase in the frequency of more transmissible variants [ 14 , 15 ] could also result in an acceleration of the epidemic. For all these reasons, it is important to respond robustly and promptly to any rebound, even those that start slowly.…”
Section: Discussionmentioning
confidence: 99%
“…The new B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (20I/501Y.V1, also called variant of concern (VOC) 202012/01) initially detected in the United Kingdom [1,2] has rapidly expanded its geographical range across European countries [3]. A large-scale genome sequencing initiative was conducted in France on 7-8 January (Flash1 survey [4], the first of a set of surveys), reporting that 3.3% of all SARS-CoV-2 detections were B.1.1.7 viruses. To limit SARS-CoV-2 spread, strengthened social distancing measures were implemented in the country in the month of January.…”
mentioning
confidence: 99%
“…The presence of the B.1.1.7 variant on the territory, however, poses critical challenges to epidemic control. Its higher transmissibility represents a strong selective advantage that makes it prone to rapidly becoming the dominant strain [1,2,[4][5][6][7][8]. Social distancing has a differential impact on the variant and the historical strains, not visible before the implementation of surveillance that monitored variant frequency over time.…”
mentioning
confidence: 99%